Terapia de genes e... O emprego

Nada sobre riscos. Apenas conversa do emprego. Deve ser bom?
http://www.bbc.com/capital/story/20181003-why-gene-therapy-will-create-so-many-jobs

Citando:
"The 44-year-old from Phoenix, Arizona, who has lived with a rare, life-threatening genetic condition known as Hunter’s Syndrome since birth, last November became the first person in the world to undergo a new type of treatment that edits genes inside his body."
(...)
"Taylor uses a powerful new gene editing tool known as CRISPR-Cas9, which harnesses part of the defence mechanism used by bacteria to edit genes in other organisms. Its invention five years ago has transformed the speed and cost of editing genes, allowing scientists to accurately delete troublesome genes or create precise breaks in the DNA where new genes can be inserted. It has spurred a surge in research to identify defective genes in diseases.

While not many diseases can simply be turned off by deleting these defective genes, CRISPR-Cas9 has opened a new door for treating patients and unravelling how other conditions might be tackled."

Estudo sobre sucesso tratamentos alternativos ao cancro

https://sol.sapo.pt/artigo/628808/estudo-diz-que-doentes-oncologicos-que-fazem-tratamentos-alternativos-t-m-uma-maior-taxa-de-mortalidade

Citando:
"De acordo com um estudo da Faculdade de Medicina da universidade de Yale, nos Estados Unidos, os doentes com cancro que optam por fazer tratamentos sem base científica comprovada, têm uma maior taxa de mortalidade.

O estudo analisou 281 casos de pessoas com cancros potencialmente curáveis, como foi o  caso de pessoas com cancro da mama, do pulmão, do colo-rectal e da próstata, ainda em fase inicial, sem que tivessem metástases noutros órgãos."

Tratamento experimental para cancro dos pulmões

Tratamento experimental recupera doente de cancro dos pulmões:

Terminally ill lung cancer patient given all clear after world first drug trial - Mirror Online

Quoting:
"Bob wasn’t responding to the drugs, and doctors told him he had around a year-and-a-half left to live. They decided to transfer him to the hospital’s clinical trials unit, and 12 months ago Bob became one of the first people ever to be treated with the brand new drug, which can’t yet be named."